Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CD4-H5224 | Human | Human CD74 / DHLAG Protein, His Tag | ![]() |
||
CD4-H524c | Human | Human CD74 / DHLAG Protein, His Tag | ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
ANG-1007 (AngioChem) | ANG-3201; ANG-1007; ANG-1009; ANG-1011; ANG-2002; ANG-2004; ANG-3101; ANG-3202; ANG-4043 | Preclinical | AngioChem | Cancer | Details |
Milatuzumab | hCD74; hLL1; IMMU-115,HCD-74 | Phase Ⅱ | Immunomedics | Chronic lymphocytic leukemia (CLL), Graft versus host disease, Multiple myeloma (MM), Systemic lupus erythematosus, Non-Hodgkin's lymphoma (NHL) | Details |
Monoclonal antibody LYM-1-I-131 | Phase Ⅱ | Northwestern University, Peregrine, Schering Pharma | Non-Hodgkin's lymphoma (NHL) | Details | |
Apolizumab | Phase Ⅱ | PDL BioPharma | Solid tumours, Non-Hodgkin's lymphoma (NHL) | Details | |
Milatuzumab doxorubicin | CD-74-DOX; hCD74-DOX; hLL1-DOX; IMMU-110 | Phase Ⅱ | Immunomedics | Chronic lymphocytic leukemia (CLL), Multiple myeloma (MM), Non-Hodgkin's lymphoma (NHL) | Details |
IMMU-114 | IMMU-114; hL243 | Phase Ⅰ | Immunomedics | Chronic lymphocytic leukemia (CLL), Non-Hodgkin's lymphoma (NHL) | Details |
Anti-CD 74 antibody drug conjugates(Sutro Biopharma) | STRO-001 | Phase Ⅰ | Sutro Biopharma | Multiple myeloma (MM), Lymphoma | Details |
This web search service is supported by Google Inc.